Author:
Niehaus Matthew,Goodmanson Nicholas,Emlet Lillian
Publisher
Springer International Publishing
Reference21 articles.
1. Van Zee A. The promotion and marketing of Oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221–7.
2. Hwang C, Chang H, Alexander G. Impact of abuse-deterrent OxyContin on prescription opioid utilization. Pharmacoepidemiol Drug Saf. 2014;24(2):197–204.
3. Jones M, Viswanath O, Peck J, Kaye A, Gill J, Simopoulos T. A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther. 2018;7(1):13–21.
4. The Opioid Epidemic by the Numbers [Internet]. HHS.gov. 2019 [cited 9 November 2019]. Available from: https://www.hhs.gov/opioids/sites/default/files/2019-11/Opioids%20Infographic_letterSizePDF_10-02-19.pdf
5. Deyo RA, Hallvik SE, Hildebran C, et al. Association between initial opioid prescribing patters and subsequent long-term use among opioid-naïve patients: a statewide retrospective cohort study. J Gen Intern Med. 2017;32:21–7.